Published online Jul 28, 2016. doi: 10.4329/wjr.v8.i7.668
Peer-review started: October 6, 2015
First decision: January 15, 2016
Revised: March 24, 2016
Accepted: April 7, 2016
Article in press: April 11, 2016
Published online: July 28, 2016
Processing time: 301 Days and 17.5 Hours
Crohn’s disease affects more than 500000 individuals in the United States, and about 25% of cases are diagnosed during the pediatric period. Imaging of the bowel has undergone dramatic changes in the past two decades. The endoscopy with biopsy is generally considered the diagnostic reference standard, this combination can evaluates only the mucosa, not inflammation or fibrosis in the mucosa. Actually, the only modalities that can visualize submucosal tissues throughout the small bowel are the computed tomography (CT) enterography (CTE) with the magnetic resonance enterography (MRE). CT generally is highly utilized, but there is growing concern over ionizing radiation and cancer risk; it is a very important aspect to keep in consideration in pediatric patients. In contrast to CTE, MRE does not subject patients to ionizing radiation and can be used to detect detailed morphologic information and functional data of bowel disease, to monitor the effects of medical therapy more accurately, to detect residual active disease even in patients showing apparent clinical resolution and to guide treatment more accurately.
Core tip: Magnetic resonance enterography is an effective imaging modality to diagnosis, evaluating and follow-up of Crohn’s disease (CD) in pediatric patient and novel magnetic resonance imaging application, such as motility studies, spectroscopy, diffusion weighted imaging, molecular and hybrid imaging are extremely interesting and might contribute to diagnosis and managment of CD.
